AudioCure Pharma: Novel compound AC102 restores noise-induced hearing loss in preclinical models

A single application of the novel compound AC102 almost completely restores noise-induced hearing loss in preclinical models.

Related Keywords

Berlin ,Germany ,Hans Rommelspacher ,Audiocure Pharma ,Audiocure Pharma Gmb ,Reimar Schlingensiepen , ,Cure Pharma ,Professor Hans Rommelspacher ,European Phase ,Compound ,Hearing ,Hearing Loss ,Reclinical ,Ear ,Efficacy ,Eurons ,Trauma ,